Home > Boards > US Listed > Biotechs > BioMarin Pharmaceutical Inc. (BMRN)

Now in regards to this, I would think

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
KingDMC Member Profile
 
Followed By 196
Posts 15,662
Boards Moderated 0
Alias Born 07/24/13
160x600 placeholder
BioMarin completes enrollment in phase 2 study of vosoritide for achondroplasia Seeking Alpha - 3/3/2021 10:06:00 AM
BioMarin Completes Full Enrollment in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondropl... PR Newswire (US) - 3/3/2021 8:31:00 AM
BioMarin Pharmaceutical EPS beats by $0.29, beats on revenue Seeking Alpha - 2/25/2021 4:11:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/25/2021 4:10:52 PM
BioMarin Announces Fourth Quarter and Record Full-year 2020 Financial Results and Corporate Updates PR Newswire (US) - 2/25/2021 4:05:00 PM
BioMarin Pharmaceutical Q4 2020 Earnings Preview Seeking Alpha - 2/24/2021 5:35:23 PM
BioMarin to Participate in Four Upcoming Virtual Investor Conferences PR Newswire (US) - 2/24/2021 8:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/22/2021 4:31:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/19/2021 5:30:04 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 2/19/2021 4:36:57 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/18/2021 6:43:42 PM
BioMarin Appoints Former Goldman Sachs Partner and Life Sciences Executive, Maykin Ho, Ph.D. to Board of Directors PR Newswire (US) - 2/18/2021 4:01:00 PM
Annual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 2/12/2021 3:11:43 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/11/2021 3:42:43 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/10/2021 10:44:12 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2021 8:04:48 AM
BioMarin Earns Top Marks in Human Rights Campaign's 2021 Corporate Equality Index PR Newswire (US) - 1/28/2021 9:00:00 AM
BioMarin to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25 at ... PR Newswire (US) - 1/26/2021 8:30:00 AM
BioMarin Announces Positive Phase 3 Gene Therapy Trial Results in Adults with Severe Hemophilia A; Study Met All Primary and ... PR Newswire (US) - 1/10/2021 6:44:00 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/7/2021 9:56:43 AM
BioMarin to Participate in Two Upcoming Virtual Investor Conferences PR Newswire (US) - 1/5/2021 8:30:00 AM
BioMarin Announces Benefit Maintained for Over Two Years in Children with Achondroplasia Treated with Vosoritide in Phase 3 E... PR Newswire (US) - 12/21/2020 8:29:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/18/2020 4:32:04 PM
BioMarin to Participate in Two Upcoming Virtual Investor Conferences PR Newswire (US) - 12/1/2020 8:30:00 AM
BioMarin and Deep Genomics to Collaborate on Advancing Programs Identified Using Artificial Intelligence PR Newswire (US) - 11/17/2020 8:29:00 AM
KingDMC   Friday, 07/17/15 10:40:15 AM
Re: TREND1 post# 655
Post # of 693 
Now in regards to this, I would think $160 near term.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
© 2021 InvestorsHub.com, Inc.
Consent Preferences